Federal authorities are accepting comments through the first week of April on newly proposed stricter guidelines for blood glucose monitoring systems.

The more stringent FDA guidance focuses on infection-control measures. For the first time, it also differentiates regulation for glucose meters used in clinical settings from those used by individuals for self-monitoring. The FDA has been working on the issue since 2010.

A draft version was published in the Federal Register Jan. 7. It covers systems used in nursing homes and hospitals.